The primary objective is to compare safety and efficacy of three induction treatments: VBMCP-VBAD / Velcade versus Thalidomide / Dexamethasone versus Velcade / Thalidomide / Dexamethasone.
Evaluate the ability of stem cell mobilization after the treatments in order to do an autologous transplant. Otherwise this study wants to compare the safety and efficacy of the maintenance treatments: Interferón a-2b versus Thalidomide
up to 65 Years (Child, Adult)
April 18, 2007
September 18, 2009
Hospital Royo Villanova Zaragoza, Aragón, Spain
Xarxa assistencial de Manresa Manresa, Barcelona, Spain